O
Formerly based in South San Francisco, California, Onyx Pharmaceuticals was engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. Amgen acquired Onyx Pharmaceuticals in 2013. See our Community Guidelines: bit.ly/smcgl
Investor insights
Funding rounds participated in
$20M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology
Sectors
Biotechnology
Date founded
1991
Funding rounds raised
Total raised
$20M
from investors over 1 rounds
O
Onyx Pharmaceuticals, Inc., an Amgen subsidiary raised $20M on June 9, 2002